Cancerous inhibitor of protein phosphatase 2A has also been found to be a prognostic factor for patients with gastric cancer (Khanna et al, 2009), early-stage tongue cancer (Bockelman et al, 2011) and non-small cell lung cancer (Dong et al, 2011). Here, CIP2A is linked to gastric cancer.